We are at the golden age of structural biology. Our ambition is to explore new scientific boundaries in protein drugging possibilities by gathering top talent, technologies and ideas.
ShuimuBio is a rapidly evolving global cryo-EM & AI platform for early drug discovery, founded in 2017 and headquartered in Beijing, China.
We are committed to drive change to empower drug discovery and accelerate the development of innovative drugs. To achieve this goal, we leverage the power of cutting-edge cryo-EM & AI technology to help our partners better understand the structures of the target proteins and complexes.
Meet the discoverers behind ShuimuBio’s
We are partnering with a team of experts consists of top talents with global backgrounds in the field of structural biology, machine learning, protein science, and drug chemistry.
Prof. Hongwei Wang
Founder丨Chairman of ShuimuBio Scientific Advisory Board
Prof. Qiangfeng Zhang
Founder丨Director of ShuimuBio Research Institute
Chunlong (Allen) Guo
Scientific Advisory Board
Prof. Guangshuo Ou
Professor at School of Life Sciences, Tsinghua University. Committed to structural biology research based on nematode models.
Prof. Yifan Cheng
Professor at UCSF, Investigator of HHMI, Election to the AAAS and NAS. Developed direct electron detection camera in cryo-EM and significantly improved SPA resolution
Prof. Hai Qi
Dean of School of Medicine, Tsinghua University. Promoted the renewal and revision of Tfh generation mechanism and development theory.
Prof. Jianlin Lei
Director of Cryo-EM Platform at Tsinghua University. Developed automated data collection software AutoEMation.
Prof. Li Yu
Professor at School of Life Sciences, Tsinghua University. Discovered a new organelle Migrating Body
Prof. Xueming Li
Professor at School of Life Sciences, Tsinghua University. Expert in electron microscope and data processing.